Stock NB3 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Neurocrine Biosciences, Inc. Deutsche Boerse AG

Equities

NB3

US64125C1099

Market Closed - Deutsche Boerse AG
Other stock markets
 07:14:16 25/06/2024 BST 		5-day change 1st Jan Change
124 EUR -0.96% Intraday chart for Neurocrine Biosciences, Inc. -1.24% +4.29%
06-13 Transcript : Neurocrine Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 10:40 AM
06-05 Transcript : Neurocrine Biosciences, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 02:30 PM

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing
MT
Neurocrine Biosciences Says CEO Kevin Gorman Retiring
MT
Neurocrine founder-CEO Gorman to retire in October
RE
Neurocrine CEO set to retire
RE
Neurocrine Biosciences, Inc. Announces Dr. Kyle Gano as Director, Effective October 11, 2024
CI
Neurocrine Biosciences Announces CEO Changes
CI
Neurocrine Biosciences Insider Sold Shares Worth $297,860, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $5,576,710, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $420,419, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $922,632, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $1,085,388, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $1,987,047, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $376,700, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $313,530, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $290,968, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $359,041, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $737,271, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $270,284, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $352,612, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. NB3 Stock
  5. News Neurocrine Biosciences, Inc.
  6. Insiders